Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07299474 · ClinicalTrials.gov registry record · NA
Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
A NA study of Thyroid Nodules and Chronic Rhinosinusitis (CRS), sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT07299474: Recruiting NA study of Thyroid Nodules and Chronic Rhinosinusitis (CRS), sponsored by Cedars-Sinai Medical Center.
NCT07299474 is a NA study of Thyroid Nodules and Chronic Rhinosinusitis (CRS) that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 184 participants, above the 122-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07299474, a NA study of Thyroid Nodules and Chronic Rhinosinusitis (CRS), is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The main questions it aims to answer are: * Does lavender aromatherapy help reduce anxiety and/or pain, and improve patient comfort during awake otolaryngologic procedures in the clinic? * Do patients subjectively find aromatherapy relaxing and/or beneficial during the procedure? Researchers will compare lavender aromatherapy to placebo (an odorless liquid) to see if lavender aromatherapy helps improve patient comfort during their awake procedure Participants will: * Have their scheduled procedure performed with lavender aromatherapy or placebo during the duration of the procedure * Take a short, less than 1 minute questionnaire both before and after the procedure, describing their levels of anxiety, pain and subjective impressions of the aromatherapy
Primary Outcome
A 10 cm visual analog scale is widely utilized to measure procedural anxiety, rated from 0 to 10, with 10 being the highest level of anxiety. The patient will provide a vertical mark above their level of anxiety. This number measured in mm (0-100) will be recorded both immediately before the procedure, and after the procedure, where the patient will record their average level of anxiety during the procedure. The change between pre-procedure, and post-procedure, will be recorded for each patient
Conditions Studied
Interventions
- OTHER Lavender Aromatherapy
- OTHER Placebo Aromatherapy
Study Locations (1)
California
- Cedars-Sinai Medical Center Otolaryngology Clinics - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2025-12 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT07299474 shows while recruiting
NCT07299474 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, above the 122-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (51% higher).
The record links to 5 conditions, with Thyroid Nodules appearing as the primary indexed condition, and to 2 interventions - of which Lavender Aromatherapy is the first listed.
NCT07299474 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07299474 about?
NCT07299474 is a clinical study titled "Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures". The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The main questions it aims to answer are: * Does lavender aromatherapy help reduce anxiety and/or pain, and improve patient ...
What is the current status of trial NCT07299474?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2025-12. Estimated completion is 2028-01.
What conditions does trial NCT07299474 study?
This clinical trial studies the following conditions: Thyroid Nodules, Chronic Rhinosinusitis (CRS), Rhinitis, Vasomotor, Inferior Turbinate Hypertrophy, Vocal Fold Immobility.
What interventions are being tested in trial NCT07299474?
The interventions under investigation include: Lavender Aromatherapy (OTHER), Placebo Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT07299474?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07299474 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
RECRUITING
-
Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study
COMPLETED
-
Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia